UCDC: Predicting Disease Severity in Males with Ornithine Transcarbamylase Deficiency
7 nov 2022 ·
2 min. 2 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on October 10, 2022,...
mostra di più
New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on October 10, 2022, titled "Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency."
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51668
Learn more about UCDC: https://www1.rarediseasesnetwork.org/cms/ucdc
mostra meno
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51668
Learn more about UCDC: https://www1.rarediseasesnetwork.org/cms/ucdc
Informazioni
| Autore | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
